Skip to main content
AAN.com

Abstract

Objective:

In patients with spontaneous intracerebral hemorrhage (ICH), the occurrence of early seizures (ES) may be a prognostic marker. Therefore, we aimed to identify incidence, associated factors, and influence on outcome of ES in patients with ICH.

Methods:

Between November 2004 and March 2009, we prospectively recruited 562 consecutive adults with a spontaneous ICH (Prognosis of InTra-Cerebral Hemorrhage cohort). Patients with previous seizures (n = 40) were excluded. ES were defined as seizures occurring within 7 days of stroke onset, and their associated factors were identified with Cox regression. For a subgroup of onset seizures, we used logistic regression. Data influencing outcome (mortality at day 7 and month 6 and functional outcome at month 6) were studied using survival analyses.

Results:

ES occurred in 71 (14%; 95% confidence interval [CI] 11–17) of 522 patients (274 male; median age 72 years, interquartile range 58–79 years). The only factor associated with ES was cortical involvement of ICH (odds ratio [OR] = 2.06; 95% CI 1.28–3.31). Regarding onset seizures (n = 38) (7%; 95% CI 5–10), associated factors were previous ICH (OR = 4.76; 95% CI 1.53–14.84), cortical involvement (OR = 2.21; 95% CI 1.11–4.43), younger age (OR = 0.97 per 1 year increase; 95% CI 0.95–0.99), and severity of the neurologic deficit at admission (OR = 1.03 per 1 point increase in the National Institutes of Health Stroke Scale score; 95% CI 1.01–1.06). ES did not influence vital or functional outcome.

Conclusions:

ES are a frequent complication in patients with spontaneous ICH; however, their occurrence does not influence outcome at 6 months.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (table_e-1.docx)
File (table_e-2.docx)

REFERENCES

1.
Menon B, Shorvon SD. Ischaemic stroke in adults and epilepsy. Epilepsy Res 2009; 87: 1–11.
2.
Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007; 38: 2001–2023.
3.
Lamy C, Domigo V, Semah F, et al. Early and late seizures after cryptogenic ischemic stroke in young adults. Neurology 2003; 60: 400–404.
4.
So EL, Annegers JF, Hauser WA, O'Brien PC, Whisnant JP. Population-based study of seizure disorders after cerebral infarction. Neurology 1996; 46: 350–355.
5.
Claassen J, Jette N, Chum F, et al. Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology 2007; 69: 1356–1365.
6.
Morgenstern LB, Hemphill JC, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010; 41: 2108–2129.
7.
Passero S, Rocchi R, Rossi S, Ulivelli M, Vatti G. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia 2002; 43: 1175–1180.
8.
Alberti A, Paciaroni M, Caso V, Venti M, Palmerini F, Agnelli G. Early seizures in patients with acute stroke: frequency, predictive factors, and effect on clinical outcome. Vasc Health Risk Manag 2008; 4: 715–720.
9.
Bladin CF, Alexandrov AV, Bellavance A, et al. Seizures after stroke: a prospective multicenter study. Arch Neurol 2000; 57: 1617–1622.
10.
Arboix A, Garcia-Eroles L, Massons JB, Oliveres M, Comes E. Predictive factors of early seizures after acute cerebrovascular disease. Stroke 1997; 28: 1590–1594.
11.
Giroud M, Gras P, Fayolle H, Andre N, Soichot P, Dumas R. Early seizures after acute stroke: a study of 1,640 cases. Epilepsia 1994; 35: 959–964.
12.
Burneo JG, Fang J, Saposnik G. Impact of seizures on morbidity and mortality after stroke: a Canadian multi-centre cohort study. Eur J Neurol 2010; 17: 52–58.
13.
Garrett MC, Komotar RJ, Starke RM, Merkow MB, Otten ML, Connolly ES. Predictors of seizure onset after intracerebral hemorrhage and the role of long-term antiepileptic therapy. J Crit Care 2009; 24: 335–339.
14.
Cordonnier C, Rutgers MP, Dumont F, et al. Intra-cerebral haemorrhages: are there any differences in baseline characteristics and intra-hospital mortality between hospital and population-based registries? J Neurol 2009; 256: 198–202.
15.
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453–1457.
16.
Cordonnier C, Leys D, Dumont F, et al. What are the causes of pre-existing dementia in patients with intracerebral haemorrhages? Brain 2010; 133: 3281–3289.
17.
Tissue plasminogen activator for acute ischemic stroke: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333: 1581–1587.
18.
Burn JP. Reliability of the modified Rankin Scale. Stroke 1992; 23: 438.
19.
Leys D, Pruvo J, Petit H, Gaudet Y, Clarisse J. Maladie d'Alzheimer: analyse statistique des résultats du scanner X. Rev Neurol 1989; 145: 134–139.
20.
Blennow K, Wallin A, Uhlemann C, Gottfries C. White-matter lesions on CT in Alzheimer patients: relationship to clinical symptomatology and vascular factors. Acta Neurol Scand 1991; 83: 187–193.
21.
Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996; 27: 1304–1305.
22.
Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia 2010; 51: 676–685.
23.
Lowenstein DH, Bleck T, Macdonald RL. It's time to revise the definition of status epilepticus. Epilepsia 1999; 40: 120–122.
24.
Guidelines for epidemiologic studies on epilepsy: Commission on Epidemiology and Prognosis, International League Against Epilepsy. Epilepsia 1993; 34: 592–596.
25.
Bryant T Confidence Interval Analysis (2.0.0, build 41). Bristol, UK: BMJ Books, 2000.
26.
Labovitz DL, Hauser WA, Sacco RL. Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology 2001; 57: 200–206.
27.
Yang TM, Lin WC, Chang WN, et al. Predictors and outcome of seizures after spontaneous intracerebral hemorrhage: clinical article. J Neurosurg 2009; 111: 87–93.
28.
Szaflarski JP, Rackley AY, Kleindorfer DO, et al. Incidence of seizures in the acute phase of stroke: a population-based study. Epilepsia 2008; 49: 974–981.
29.
Weisberg LA, Shamsnia M, Elliott D. Seizures caused by nontraumatic parenchymal brain hemorrhages. Neurology 1991; 41: 1197–1199.
30.
Sung CY, Chu NS. Epileptic seizures in intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 1989; 52: 1273–1276.
31.
Bateman BT, Claassen J, Willey JZ, et al. Convulsive status epilepticus after ischemic stroke and intracerebral hemorrhage: frequency, predictors, and impact on outcome in a large administrative dataset. Neurocrit Care 2007; 7: 187–193.
32.
Rumbach L, Sablot D, Berger E, Tatu L, Vuillier F, Moulin T. Status epilepticus in stroke: report on a hospital-based stroke cohort. Neurology 2000; 54: 350–354.
33.
Vespa PM, O'Phelan K, Shah M, et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology 2003; 60: 1441–1446.
34.
Kilpatrick CJ, Davis SM, Tress BM, Rossiter SC, Hopper JL, Vandendriesen ML. Epileptic seizures in acute stroke. Arch Neurol 1990; 47: 157–160.
35.
Willmore LJ. Post-traumatic seizures. Neurol Clin 1993; 11: 823–834.
36.
Leira R, Davalos A, Silva Y, et al. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology 2004; 63: 461–467.

Information & Authors

Information

Published In

Neurology®
Volume 77Number 20November 15, 2011
Pages: 1794-1800
PubMed: 21975203

Publication History

Received: December 28, 2010
Accepted: April 20, 2011
Published online: October 5, 2011
Published in print: November 15, 2011

Permissions

Request permissions for this article.

Disclosure

Dr. De Herdt has served on a scientific advisory board for UCB and received funding for travel from Janssen. Dr. Dumont reports no disclosures, Dr. Hénon has received research support from sanofi-aventis, Servier, EBEWE Pharma, CoLucid Pharmaceuticals, PhotoThera, and BrainsGate. Dr. Derambure has served on scientific advisory boards for GlaxoSmithKline and Eisai Inc.; has received funding for travel from Eisai Inc.; has received speaker honoraria from Eisai Inc. and UCB; serves on the editorial board of Clinical Neurophysiology; and has received research support from GlaxoSmithKline and UCB. Dr. Vonck has received speaker honoraria from Cyberonics, Inc., UCB, and Pfizer, Inc. Dr. Leys has had consultancy roles and has contributed to advisory boards, steering committees, and adjudication committees for sanofi-aventis, Servier, Boehringer Ingelheim, AstraZeneca, Allergan, Inc., EBEWE Pharma, and Novo Nordisk, fees for which were paid toward research at ADRINORD (Association pour le Développement de la Recherche et de l'Innovation dans le Nord-Pas de Calais) or the research account of the hospital (délégation à la recherche du CHU de Lille); and was reimbursed for travel or accommodation expenses needed for the participation on these boards and committees. Dr. Cordonnier has received research support from sanofi-aventis, PhotoThera, and BrainsGate.

Authors

Affiliations & Disclosures

V. De Herdt, MD, PhD
From the Department of Neurology (V.D.H., F.D., H.H., P.D., D.L., C.C.), Université Lille Nord de France, UDSL, CHU Lille, EA1046, Lille, France; and Department of Neurology (V.D.H., K.V.), Reference Center for Refractory Epilepsy, Ghent University Hospital, Ghent, Belgium.
F. Dumont, MD
From the Department of Neurology (V.D.H., F.D., H.H., P.D., D.L., C.C.), Université Lille Nord de France, UDSL, CHU Lille, EA1046, Lille, France; and Department of Neurology (V.D.H., K.V.), Reference Center for Refractory Epilepsy, Ghent University Hospital, Ghent, Belgium.
H. Hénon, MD, PhD
From the Department of Neurology (V.D.H., F.D., H.H., P.D., D.L., C.C.), Université Lille Nord de France, UDSL, CHU Lille, EA1046, Lille, France; and Department of Neurology (V.D.H., K.V.), Reference Center for Refractory Epilepsy, Ghent University Hospital, Ghent, Belgium.
P. Derambure, MD, PhD
From the Department of Neurology (V.D.H., F.D., H.H., P.D., D.L., C.C.), Université Lille Nord de France, UDSL, CHU Lille, EA1046, Lille, France; and Department of Neurology (V.D.H., K.V.), Reference Center for Refractory Epilepsy, Ghent University Hospital, Ghent, Belgium.
K. Vonck, MD, PhD
From the Department of Neurology (V.D.H., F.D., H.H., P.D., D.L., C.C.), Université Lille Nord de France, UDSL, CHU Lille, EA1046, Lille, France; and Department of Neurology (V.D.H., K.V.), Reference Center for Refractory Epilepsy, Ghent University Hospital, Ghent, Belgium.
D. Leys, MD, PhD
From the Department of Neurology (V.D.H., F.D., H.H., P.D., D.L., C.C.), Université Lille Nord de France, UDSL, CHU Lille, EA1046, Lille, France; and Department of Neurology (V.D.H., K.V.), Reference Center for Refractory Epilepsy, Ghent University Hospital, Ghent, Belgium.
C. Cordonnier, MD, PhD
From the Department of Neurology (V.D.H., F.D., H.H., P.D., D.L., C.C.), Université Lille Nord de France, UDSL, CHU Lille, EA1046, Lille, France; and Department of Neurology (V.D.H., K.V.), Reference Center for Refractory Epilepsy, Ghent University Hospital, Ghent, Belgium.

Notes

Address correspondence and reprint requests to Dr. Charlotte Cordonnier, Université Lille Nord de France, UDSL, CHU Lille, EA 1046, Neurology Department, F-59000, Lille, France [email protected]

Author Contributions

Dr. De Herdt analyzed and interpreted all data, contributed to study design, performed statistical analysis, and drafted the manuscript. Dr. Dumont collected the study data. Dr. Hénon conceptualized and designed the study, interpreted and collected study data, and revised the manuscript. Dr. Derambure contributed to data collection and revised the manuscript. Dr. Vonck revised the manuscript. Dr. Leys conceptualized the study, collected study data, and revised the manuscript, Dr. Cordonnier collected study data, designed and conceptualized the study, analyzed and interpreted all data, performed statistical analysis, and drafted the manuscript.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Predictive value of hyponatremia for short-term mortality in supratentorial spontaneous intracerebral hemorrhage: a single center study, Frontiers in Neurology, 15, (2024).https://doi.org/10.3389/fneur.2024.1301197
    Crossref
  2. Telemedicine Protocols for the Management of Patients with Acute Spontaneous Intracerebral Hemorrhage in Rural and Medically Underserved Areas in Gangwon State : Recommendations for Doctors with Less Expertise at Local Emergency Rooms, Journal of Korean Neurosurgical Society, 67, 4, (385-396), (2024).https://doi.org/10.3340/jkns.2023.0199
    Crossref
  3. Emergent Management of Intracerebral Hemorrhage, CONTINUUM: Lifelong Learning in Neurology, 30, 3, (641-661), (2024).https://doi.org/10.1212/CON.0000000000001422
    Crossref
  4. Early seizures and risk of epilepsy and death after intracerebral haemorrhage: The MUCH Italy, European Stroke Journal, 9, 3, (630-638), (2024).https://doi.org/10.1177/23969873241247745
    Crossref
  5. Acute seizures after spontaneous intracerebral hemorrhage in young individuals: 11-year trends and association with mortality, Epilepsy Research, 205, (107408), (2024).https://doi.org/10.1016/j.eplepsyres.2024.107408
    Crossref
  6. Intracerebral Hemorrhage, Case-based Approach to Common Neurological Disorders, (97-103), (2024).https://doi.org/10.1007/978-981-99-8676-7_12
    Crossref
  7. Intracerebral Hemorrhage, Handbook of Cerebrovascular Disease and Neurointerventional Technique, (965-1000), (2024).https://doi.org/10.1007/978-3-031-45598-8_17
    Crossref
  8. Pregnancy‐Related Stroke, Critical Care Obstetrics, (737-773), (2024).https://doi.org/10.1002/9781119820260.ch42
    Crossref
  9. The therapeutic effects of lacosamide on epilepsy-associated comorbidities, Frontiers in Neurology, 14, (2023).https://doi.org/10.3389/fneur.2023.1063703
    Crossref
  10. Microbleeds Due to Reperfusion Enhance Early Seizures after Carotid Ligation in a Rat Ischemic Model, Neurologia medico-chirurgica, 63, 6, (228-235), (2023).https://doi.org/10.2176/jns-nmc.2022-0372
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share